🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine, with Positron Emission Tomograph...
Status
Completed
Location
Washington University School of Medicine
Start Date
2005-09
Trial ID
NCT00603720
Treatments Being Tested
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregional...
Status
Completed
Location
Xiaozhong Chen
Start Date
2017-03-13
Trial ID
NCT03025958
Treatments Being Tested
The proposed study will recruit patients with mild to moderate Fuch's dystr...
Status
Withdrawn
Location
Hotel Dieu Hospital
Start Date
2014-04
Trial ID
NCT02109276
Treatments Being Tested
To determine if a high-dose first-line regimen is non-inferior (non-inferio...
Status
Recruiting
Location
Damien Foundation
Start Date
2021-03-01
Trial ID
NCT04260477
This first-in-human study will establish the human safety and radiation dos...
Status
Not Yet Recruiting
Location
UAB
Start Date
2027-04-01
Trial ID
NCT05676489
Treatments Being Tested
This phase II trial studies pentostatin and donor lymphocyte infusion in pr...
Status
Completed
Location
Huntsman Cancer Institute/University of Utah
Start Date
2003-05
Trial ID
NCT00096161
Treatments Being Tested
The objective of this study is to determine the long-term safety and effect...
Status
Completed
Location
AZ Nikolaas
Start Date
2009-05-18
Trial ID
NCT04399928
Treatments Being Tested
Combining nimotuzumab to gefitinib may not only potentiate cellular cytotox...
Status
Completed
Location
Severance hospital, Yonsei Cancer Center
Start Date
2011-12
Trial ID
NCT01498562
Treatments Being Tested
Main objective is to investigate mutual pharmacokinetic drug-drug interacti...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2016-08-22
Trial ID
NCT02854527
Treatments Being Tested
This is a randomized, open-label, multicenter phase II study to evaluate th...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2025-06-08
Trial ID
NCT07069569
Treatments Being Tested